Tan Qiu-Hong, Liu Lin, Huang Yu-Qing, Yu Yu-Ling, Huang Jia-Yi, Chen Chao-Lei, Tang Song-Tao, Feng Ying-Qing
School of Biology and Biological Engineering, South China University of Technology, Guangzhou, China.
Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Front Cardiovasc Med. 2021 Sep 21;8:717128. doi: 10.3389/fcvm.2021.717128. eCollection 2021.
Limited studies focused on the association between serum uric acid (SUA) change with ischemic stroke, and their results remain controversial. The present study aimed to investigate the relationship between change in SUA with ischemic stroke among hypertensive patients. This was a retrospective cohort study. We recruited adult hypertensive patients who had two consecutive measurements of SUA levels from 2013 to 2014 and reported no history of stroke. Change in SUA was assessed as SUA concentration measured in 2014 minus SUA concentration in 2013. Multivariable Cox proportional hazards models were used to estimate adjusted hazard ratios (HRs) and 95% confidence intervals (CIs). The Kaplan-Meier analysis and log-rank test were performed to quantify the difference in cumulative event rate. Additionally, subgroup analysis and interaction tests were conducted to investigate heterogeneity. A total of 4,628 hypertensive patients were included, and 93 cases of ischemic stroke occurred during the mean follow-up time of 3.14 years. Participants were categorized into three groups according to their SUA change tertiles [low (SUA decrease substantially): <-32.6 μmol/L; middle (SUA stable): ≥-32.6 μmol/L, <40.2 μmol/L; high (SUA increase substantially): ≥40.2 μmol/L]. In the fully adjusted model, setting the SUA stable group as reference, participants in the SUA increase substantially group had a significantly elevated risk of ischemic stroke [HR (95% CI), 1.76 (1.01, 3.06), = 0.0451], but for the SUA decrease substantially group, the hazard effect was insignificant [HR (95% CI), 1.31 (0.75, 2.28), = 0.3353]. Age played an interactive role in the relationship between SUA change and ischemic stroke. Younger participants (age < 65 years) tended to have a higher risk of ischemic stroke when SUA increase substantially. SUA increase substantially was significantly correlated with an elevated risk of ischemic stroke among patients with hypertension.
仅有少数研究聚焦于血清尿酸(SUA)变化与缺血性卒中之间的关联,且研究结果仍存在争议。本研究旨在调查高血压患者中SUA变化与缺血性卒中之间的关系。这是一项回顾性队列研究。我们纳入了2013年至2014年连续两次测量SUA水平且无卒中病史的成年高血压患者。SUA变化评估为2014年测量的SUA浓度减去2013年的SUA浓度。采用多变量Cox比例风险模型来估计调整后的风险比(HR)和95%置信区间(CI)。进行Kaplan-Meier分析和对数秩检验以量化累积事件率的差异。此外,进行亚组分析和交互作用检验以调查异质性。总共纳入了4628例高血压患者,在平均3.14年的随访时间内发生了93例缺血性卒中。参与者根据其SUA变化三分位数分为三组[低(SUA大幅下降):<-32.6 μmol/L;中(SUA稳定):≥-32.6 μmol/L,<40.2 μmol/L;高(SUA大幅上升):≥40.2 μmol/L]。在完全调整模型中,将SUA稳定组作为参照,SUA大幅上升组的参与者发生缺血性卒中的风险显著升高[HR(95%CI),1.76(1.01,3.06),P = 0.0451],但对于SUA大幅下降组,风险效应不显著[HR(95%CI),1.31(0.75,2.28),P = 0.3353]。年龄在SUA变化与缺血性卒中的关系中起交互作用。较年轻的参与者(年龄<65岁)在SUA大幅上升时发生缺血性卒中的风险往往更高。SUA大幅上升与高血压患者缺血性卒中风险升高显著相关。